Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 158
Selected: 0
NCT IDTitle
NCT00801216High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement
NCT01079117Morphine Slow-release Capsules in Substitution Therapy
NCT02693769A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils
NCT03141554The Effect of Oral Antiseptic Gargles on the Oral Cavity Microbiome
NCT00992576Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain
NCT01821040A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR
NCT01289223A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab.
NCT02321397To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT00995800Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma
NCT01558167A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia
NCT03348917The Effect of Skin Cleansers on the Skin Surface Microbiome
NCT01710917A Non-interventional, Observational Study for Quality of Life (Overall Health Assessment) in Patients With Chronic Severe Pain During Targinact® Treatment
NCT01739387A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI)
NCT01439100A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain
NCT01710904A Non-interventional, Observational Study for Targinact® Treatment in Patients With Chronic Severe Pain
NCT02732886Betafoam Diabetes Mellitus Foot Study
NCT01167127Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT02326454A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT01325194CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis
NCT01083485OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty
NCT00513656A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain
NCT01811186An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)
NCT01526694Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM
NCT00346047Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Low Back Pain
NCT03398278OTR Tablet 40 mg Fasted-state Bioequivalence Study
NCT01109511A Comparison of Oxycodone/Naloxone and Oxycodone After Laparoscopic Hysterectomy
NCT01811238An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders
NCT02256202Quality Assurance of Electronic Data Capturing (EDC) in Pain Treatment
NCT01983137A Non-interventional, Observational Study for Targinact® Treatment in Patients With Severe Pain.
NCT01376401Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
NCT00854867Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.
NCT03176199A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain
NCT03176121Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain
NCT03380247Multimodal Oral Analgesia for Trauma in the Emergency Department
NCT00823355Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies
NCT02133820A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State.
NCT02431624An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion
NCT01776411Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients
NCT03768466Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment
NCT01643772OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study
NCT02195375Flutiform® Compared With Seretide® in the Treatment of COPD
NCT02013362Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
NCT05432375Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
NCT03967327A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain
NCT03492775First Line Therapy of Advanced Stage Follicular Lymphoma in Patients < 60 Years Not Eligible fo Standard Immunochemotherapy and in All Patients ≥ 60 Years
NCT01511367Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients
NCT03155516Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain Patients
NCT01812733Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives
NCT03403504OTR Tablet 10 mg Fasted-state Bioequivalence Study
NCT00959686Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma